Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M214,571Revenue $M49,605Net Margin (%)18.4Z-Score2.7
Enterprise Value $M215,481EPS $1.4Operating Margin %25.6F-Score6
P/E(ttm))24.5Cash Flow Per Share $3.5Pre-tax Margin (%)24.7Higher ROA y-yN
Price/Book3.110-y EBITDA Growth Rate %3.0Quick Ratio2.4Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %5.0Current Ratio2.7Lower Leverage y-yN
Price/Cash Flow7.2y-y EBITDA Growth Rate %-16.8ROA % (ttm)5.3Higher Current Ratio y-yY
Dividend Yield %3.0Insider Buy (3m)0ROE % (ttm)12.0Less Shares Outstanding y-yY
Payout Ratio %74.0Shares Outstanding M6,129ROI % (ttm)21.6Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PFEIrving Kahn 2014-12-31 Reduce-0.49%$27.7 - $32.09
($30.23)
$ 35.0114%Reduce -5.14%1,883,217
PFEJean-Marie Eveillard 2014-12-31 Add0.39%$27.7 - $32.09
($30.23)
$ 35.0114%Add 3786.85%5,272,943
PFERichard Pzena 2014-12-31 Buy 0.36%$27.7 - $32.09
($30.23)
$ 35.0114%New holding2,170,568
PFEVanguard Health Care Fund 2014-12-31 Add0.32%$27.7 - $32.09
($30.23)
$ 35.0114%Add 29.88%19,395,622
PFEMichael Price 2014-12-31 Sold Out -0.17%$27.7 - $32.09
($30.26)
$ 35.0114%Sold Out0
PFEIrving Kahn 2014-09-30 Reduce-0.59%$28.04 - $30.96
($29.58)
$ 35.0116%Reduce -6.56%1,985,161
PFEMichael Price 2014-09-30 Reduce-0.22%$28.04 - $30.96
($29.58)
$ 35.0116%Reduce -56.02%47,100
PFEJean-Marie Eveillard 2014-09-30 Reduce-0.16%$28.04 - $30.96
($29.58)
$ 35.0116%Reduce -94.11%135,661
PFEHOTCHKIS & WILEY 2014-09-30 Sold Out -0.01%$28.04 - $30.96
($29.58)
$ 35.0116%Sold Out0
PFENWQ Managers 2014-06-30 Reduce-0.81%$29.02 - $32.4
($30.05)
$ 35.0114%Reduce -31.07%6,363,006
PFEVanguard Health Care Fund 2014-06-30 Add0.62%$29.02 - $32.4
($30.05)
$ 35.0114%Add 105.23%14,934,022
PFEDodge & Cox 2014-06-30 Reduce-0.5%$29.02 - $32.4
($30.05)
$ 35.0114%Reduce -23.73%48,902,097
PFEJean-Marie Eveillard 2014-06-30 Reduce-0.47%$29.02 - $32.4
($30.05)
$ 35.0114%Reduce -70.71%2,303,762
PFEJoel Greenblatt 2014-06-30 Add0.27%$29.02 - $32.4
($30.05)
$ 35.0114%Add 71.59%1,741,314
PFECharles Brandes 2014-06-30 Add0.12%$29.02 - $32.4
($30.05)
$ 35.0114%Add 5.78%6,075,460
PFEHOTCHKIS & WILEY 2014-06-30 Reduce-0.01%$29.02 - $32.4
($30.05)
$ 35.0114%Reduce -33.68%128,800
PFEIrving Kahn 2014-03-31 Add0.98%$29.66 - $32.75
($31.36)
$ 35.0110%Add 11.22%2,112,819
PFEVanguard Health Care Fund 2014-03-31 Reduce-0.48%$29.66 - $32.75
($31.36)
$ 35.0110%Reduce -40.13%7,276,622
PFENWQ Managers 2014-03-31 Reduce-0.39%$29.66 - $32.75
($31.39)
$ 35.0110%Reduce -13.60%9,231,207
PFEJoel Greenblatt 2014-03-31 Add0.38%$29.66 - $32.75
($31.39)
$ 35.0110%Add 356.54%1,014,808
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PFE is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SUSMAN SALLYExecutive Vice President 2015-03-12Sell46,179$343.44view
READ IAN CChairman & CEO 2015-03-05Sell67,500$34.621.59view
Dolsten MikaelPresident R&D 2015-03-05Sell58,298$34.462.06view
CANGIALOSI LORETTA VSr. Vice President, Controller 2015-02-13Sell104,000$34.731.27view
MADDALUNA ANTHONY JExecutive Vice President 2015-02-12Sell9,000$34.850.92view
DAMELIO FRANK AExecutive Vice President 2015-02-11Sell14,800$34.32.54view
DAMELIO FRANK AExecutive Vice President 2015-02-11Sell80,200$34.232.75view
MADDALUNA ANTHONY JExecutive Vice President 2015-02-10Sell9,000$33.784.11view
MADDALUNA ANTHONY JExecutive Vice President 2014-12-08Sell6,500$329.91view
HILL CHARLES HExecutive Vice President 2014-11-10Sell8,285$30.1816.53view

Press Releases about PFE :

    Quarterly/Annual Reports about PFE:

      News about PFE:

      Articles On GuruFocus.com
      Bristol-Myers Signs An Exclusive Pact In Gene Therapy For Treating Cardiovascular Disorders Apr 08 2015 
      Pfizer Meets New Challenges In Its Vaccine Operations In China Apr 07 2015 
      Pfizer Halts Its Vaccine Business In China Apr 06 2015 
      Analyzing James Barrow's Top Holdings: Pfizer Inc. Apr 01 2015 
      A Look at Pharma Company Dermira's Performance Mar 27 2015 
      What Are The Intrinsic Factors Contributing To Pfizer’s Stock Movement? Mar 27 2015 
      Biogen And Idec To Part Ways After Inventing Alzheimer's Drug Mar 27 2015 
      DE Mar 24 2015 
      Pfizer In The Process Of Making Path Breaking Vaccine Mar 18 2015 
      A look at Jean-Marie Eveillard's investment in Pfizer Mar 17 2015 

      More From Our Partners
      Stock Market News for April 13, 2015 - Market News Apr 13 2015 - ZACKS

      More From Other Websites
      The 4 Stocks That Sank the Dow on Monday Apr 13 2015
      Mylan settles Viagra patent litigation with Pfizer Apr 13 2015
      Pfizer Inc. (PFE) Helped Kahn Brothers Beat the Market Despite BlackBerry Ltd (BBRY) Losses Apr 13 2015
      Pfizer Accused of Knowing Zoloft Posed Birth Risk Apr 13 2015
      The 5 Most Shorted NYSE Stocks at the End of Q1 Apr 13 2015
      Polio Vaccine Found "Safe And Effective" 60 Years Ago: What Would Salk Think Today? Apr 13 2015
      Biotech Ligand Gets Sweeter Deal From Partner Viking Apr 10 2015
      Valeant VP’s $50.6 Million Pay Second to Apple Among Non-CEOs Apr 10 2015
      Pfizer (PFE) Stock Is the 'Chart of the Day' Apr 10 2015
      Pharmalot…Pharmalittle…Good Morning: We're Catching up on Eisai, HepC Research, Pfizer and Ebola Apr 10 2015
      The 4 Stocks That Lifted the Dow on Thursday Apr 09 2015
      Buy These 5 Blue-Chip Stocks for Breakout Gains in April Apr 09 2015
      Everything is up for grabs in pharmaceuticals: Pro Apr 09 2015
      Big Losses in BlackBerry Ltd (BBRY) Weigh on Prem Watsa’s Fairfax Financial; Picks Lost 8% in Q1 Apr 09 2015
      Pfizer Launches First Annual PCSK9 Competitive Grants Program to Advance Cardiovascular Disease... Apr 09 2015
      Pfizer Launches First Annual PCSK9 Competitive Grants Program to Advance Cardiovascular Disease... Apr 09 2015
      Mylan offers about $29B for rival generic drugmaker Perrigo Apr 08 2015
      Mylan offers about $29B for rival generic drugmaker Perrigo Apr 08 2015
      Hospira Slammed with Another Warning Letter by the FDA - Analyst Blog Apr 08 2015
      Hospira hit with further FDA scrutiny after $17 billion Pfizer deal Apr 08 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      SEENSCO
      ReplySEENSCO - 10 months ago
      PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK